Silo Pharma (SIextrusionLO) said Wednesday it entered a new agreement with Sever Pharma Solutions to scale the production of its SP-26 product.
SP-26 is a ketamine-loaded implant designed to treat fibromyalgia and chronic pain.
Sever Pharma will also conduct further analytical testing on the implants to ensure they work as intended over a controlled period of time, Silo Pharma said.
Price: 1.38, Change: +0.13, Percent Change: +10.40
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments